Evaluation of antibiotic resistance, toxin-antitoxin systems, virulence factors, biofilm-forming strength and genetic linkage of Escherichia coli strains isolated from bloodstream infections of leukemia patients

被引:7
作者
Roshani, Mahdaneh [1 ]
Taheri, Mohammad [1 ]
Goodarzi, Alireza [2 ]
Yosefimashouf, Rassoul [1 ]
Shokoohizadeh, Leili [3 ]
机构
[1] Hamadan Univ Med Sci, Fac Med, Dept Microbiol, Hamadan, Iran
[2] Hamadan Univ Med Sci, Infect Dis Res Ctr, Hamadan, Iran
[3] Hamadan Univ Med Sci, Sch Paramedicine, Dept Med Lab Sci, Hamadan, Iran
关键词
Escherichia coli; Blood stream Infections (BSIs); Leukemia; Toxin-antitoxin systems; Virulence factor; SPECTRUM; PLASMID; IMPACT; ENTEROBACTERIACEAE; EPIDEMIOLOGY; MALIGNANCIES; PREVALENCE; PREDICTORS; BACTEREMIA; EMERGENCE;
D O I
10.1186/s12866-023-03081-8
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background One of the most common complications in patients with febrile neutropenia, lymphoma, leukemia, and multiple myeloma is a bloodstream infection (BSI).Objective This study aimed to evaluate the antibiotic resistance patterns, virulence factors, biofilm-forming strength, and genetic linkage of Escherichia coli strains isolated from bloodstream infections (BSIs) of leukemia patients.Methods The study conducted in Iran from June 2021 to December 2022, isolated 67 E. coli strains from leukemia patients' bloodstream infections in hospitals in two different areas. Several techniques including disk diffusion and broth microdilution were used to identify patterns of antibiotic resistance, microtiter plate assay to measure biofilm formation, and PCR to evaluate the prevalence of different genes such as virulence factors, toxin-antitoxin systems, resistance to beta-lactams and fluoroquinolone antibiotics of E. coli strains. Additionally, the genetic linkage of the isolates was analyzed using the Enterobacterial Repeat Intergenic Consensus Polymerase Chain Reaction (ERIC-PCR) method.Results The results showed that higher frequency of BSI caused by E. coli in man than female patients, and patients with acute leukemia had a higher frequency of BSI. Ampicillin and Amoxicillin-clavulanic acid showed the highest resistance, while Imipenem was identified as a suitable antibiotic for treating BSIs by E. coli. Multidrug-resistant (MDR) phenotypes were present in 22% of the isolates, while 53% of the isolates were ESBL-producing with the blaCTX-M gene as the most frequent beta-lactamase gene. The fluoroquinolone resistance genes qnrB and qnrS were present in 50% and 28% of the isolates, respectively. More than 80% of the isolates showed the ability to form biofilms. The traT gene was more frequent than other virulence genes. The toxin-antitoxin system genes (mazF, ccdAB, and relB) showed a comparable frequency. The genetic diversity was detected in E. coli isolates.Conclusion Our results demonstrate that highly diverse, resistant and pathogenic E. coli clones are circulating among leukemia patients in Iranian hospitals. More attention should be paid to the treatment and management of E. coli bloodstream infections in patients with leukemia.
引用
收藏
页数:12
相关论文
共 60 条
[1]  
Alsharif AR., 2021, Int J Infect Dis, V105, P370
[2]  
[Anonymous], 2014, PERFORMANCE STANDARD, V24th
[3]   Pathogenomics and clinical recurrence influence biofilm capacity of Escherichia coli isolated from canine urinary tract infections [J].
Ballash, Gregory A. ;
Mollenkopf, Dixie F. ;
Diaz-Campos, Dubraska ;
van Balen, Joany C. ;
Cianciolo, Rachel E. ;
Wittum, Thomas E. .
PLOS ONE, 2022, 17 (08)
[4]   Detection of virulence factors in α-haemolytic Escherichia coli strains isolated from various clinical materials [J].
Birosová, E ;
Siegfried, L ;
Kmet'ová, M ;
Makara, A ;
Ostró, A ;
Gresová, A ;
Urdzík, P ;
Liptáková, A ;
Molokácová, M ;
Bártl, R ;
Valansky, L .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (06) :569-573
[5]   Prospective Study of Fecal Colonization by Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Neutropenic Patients with Cancer [J].
Calatayud, L. ;
Arnan, M. ;
Linares, J. ;
Dominguez, M. A. ;
Gudiol, C. ;
Carratala, J. ;
Batlle, M. ;
Ribera, J. M. ;
Gudiol, F. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (11) :4187-4190
[6]   Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies:: results of a prospective study on 823 patients at a single institution [J].
Cattaneo, C. ;
Quaresmini, G. ;
Casari, S. ;
Capucci, M. A. ;
Micheletti, M. ;
Borlenghi, E. ;
Signorini, L. ;
Re, A. ;
Carosi, G. ;
Rossi, G. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) :721-728
[7]  
Chakraborty S., 2015, Infect Dis, V47, P141
[8]   Extra-intestinal pathogenic Escherichia coli (ExPEC): Disease, carriage and clones [J].
Dale, Adam P. ;
Woodford, Neil .
JOURNAL OF INFECTION, 2015, 71 (06) :615-626
[9]  
De Majumdar S., 2021, J Infect Dis, V223, P428
[10]   Management of febrile neutropenia: ESMO Clinical Practice Guidelines [J].
de Naurois, J. ;
Novitzky-Basso, I. ;
Gill, M. J. ;
Marti, F. Marti ;
Cullen, M. H. ;
Roila, F. .
ANNALS OF ONCOLOGY, 2010, 21 :v252-v256